| Literature DB >> 33924417 |
Tero Sievänen1, Timo Törmäkangas1, Eija K Laakkonen1, Jukka-Pekka Mecklin2,3, Kirsi Pylvänäinen4, Toni T Seppälä5,6, Päivi Peltomäki7, Sarianna Sipilä1, Elina Sillanpää1,8.
Abstract
Lynch syndrome (LS) increases cancer risk. There is considerable individual variation in LS cancer occurrence, which may be moderated by lifestyle factors, such as body weight and physical activity (PA). The potential associations of lifestyle and cancer risk in LS are understudied. We conducted a retrospective study with cancer register data to investigate associations between body weight, PA, and cancer risk among Finnish LS carriers. The participants (n = 465, 54% women) self-reported their adulthood body weight and PA at 10-year intervals. Overall cancer risk and colorectal cancer (CRC) risk was analyzed separately for men and women with respect to longitudinal and near-term changes in body weight and PA using extended Cox regression models. The longitudinal weight change was associated with an increased risk of all cancers (HR 1.02, 95% CI 1.00-1.04) and CRC (HR 1.03, 1.01-1.05) in men. The near-term weight change was associated with a lower CRC risk in women (HR 0.96, 0.92-0.99). Furthermore, 77.6% of the participants retained their PA category over time. Men in the high-activity group had a reduced longitudinal cancer risk of 63% (HR 0.37, 0.15-0.98) compared to men in the low-activity group. PA in adulthood was not associated with cancer risk among women. These results emphasize the role of weight maintenance and high-intensity PA throughout the lifespan in cancer prevention, particularly in men with LS.Entities:
Keywords: epidemiology; hereditary non-polyposis colorectal cancer; lifestyle
Year: 2021 PMID: 33924417 PMCID: PMC8069994 DOI: 10.3390/cancers13081849
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639
Descriptive demographic, genetic, cancer history, socioeconomic, and lifestyle-related characteristics of the study population.
| Background Variable | Men | Women | ||
|---|---|---|---|---|
| Cancer | Healthy | Cancer | Healthy | |
| Age at data collection (years (SD)) | 64.2 (11.2) | 49.5 (14.0) | 65.4 (9.6) | 49.7 (14.0) |
| Age at first cancer (years (SD)) | 45.9 (10.4) | 48.6 (29–79) | ||
| Age at first CRC (years (SD)) | 45.6 (11.1) | 48.4 (29–79) | ||
| Cancers diagnosed ( | ||||
| CRC | 89 (88.1) | 77 (63.1) | ||
| Endometrial cancer | 17 (16.8) | 57 (46.7) | ||
| Other cancers a | 30 (24.6) | |||
| MMR gene affected ( | ||||
|
| 50 (49.5) | 56 (49.1) | 50 (41.0) | 64 (50.0) |
| 24 (23.8) | 26 (22.8) | 35 (28.7) | 34 (26.6) | |
|
| 15 (14.9) | 22 (19.3) | 26 (21.3) | 13 (10.2) |
|
| 10 (9.9) | 10 (8.8) | 11 (9.0) | 17 (13.3) |
|
| 2 (2.0) | |||
| Socioeconomic characteristics | ||||
| Education ( | ||||
| Basic education | 20 (19.8) | 13 (11.4) | 36 (29.5) | 16 (12.5) |
| Upper secondary degrees | 46 (45.6) | 60 (52.6) | 51 (41.8) | 63 (49.4) |
| Polytechnic degree | 13 (12.9) | 18 (15.8) | 11 (9.0) | 19 (14.8) |
| University degree | 22 (21.8) | 23 (20.2) | 24 (19.7) | 30 (23.4) |
| Occupational status ( | ||||
| Worker/employee | 40 (39.6) | 76 (66.7) | 47 (39.2) | 92 (72.4) |
| Retired | 45 (44.6) | 18 (15.8) | 56 (46.7) | 22 (17.3) |
| Other b | 16 (15.8) | 20 (17.5) | 17 (14.2) | 13 (10.3) |
| Marital status ( | ||||
| Living alone | 20 (19.8) | 22 (19.3) | 40 (32.8) | 32 (25.0) |
| Married/cohabitation | 81 (80.2) | 92 (80.7) | 82 (67.2) | 96 (75.0) |
| Perceived health and physical fitness | ||||
| Self-rated health ( | ||||
| Poor | 16 (15.8) | 13 (11.4) | 15 (12.3) | 19 (14.8) |
| Average | 39 (38.6) | 27 (23.7) | 49 (40.2) | 32 (25.0) |
| Good | 46 (45.5) | 74 (64.9) | 57 (46.7) | 77 (60.2) |
| Self-rated physical fitness ( | ||||
| Poor | 22 (21.8) | 18 (15.8) | 16 (13.1) | 21 (16.4) |
| Average | 39 (38.6) | 29 (25.4) | 50 (41.0) | 40 (31.3) |
| Good | 40 (39.6) | 67 (58.8) | 56 (45.9) | 67 (52.3) |
| Lifestyle variables | ||||
| Alcohol consumption (portions/week (SD)) # | 4.8 (6.5) | 4.8 (5.3) | 2.3 (3.5) | 3.0 (4.3) |
| Smoking status ( | ||||
| Never | 43 (42.6) | 45 (39.5) | 61 (50.0) | 64 (50.0) |
| Former | 47 (46.5) | 48 (42.1) | 52 (42.6) | 46 (35.9) |
| Current | 11 (10.9) | 21 (18.4) | 8 (6.6) | 17 (13.3) |
| Use of anti-inflammatory drugs ( | ||||
| No | 83 (85.6) | 89 (78.1) | 88 (72.7) | 84 (65.6) |
| Yes | 14 (14.4) | 25 (21.9) | 33 (27.3) | 44 (34.4) |
| Current physical activity ( | ||||
| Low | 28 (28.0) | 23 (20.2) | 23 (18.9) | 21 (16.4) |
| Medium | 32 (32.0) | 24 (21.1) | 44 (36.1) | 47 (36.7) |
| High | 40 (40.0) | 67 (58.8) | 55 (45.1) | 60 (46.9) |
| BMI (kg/m2 (SD)) # | 27.2 (5.3) | 26.6 (4.2) | 27.1 (5.8) | 27.6 (11.6) |
| BMI categories ( | ||||
| Underweight | 2 (2.0) | 2 (1.8) | 1 (0.8) | 2 (1.6) |
| Normal weight | 40 (40.0) | 38 (33.3) | 48 (40.7) | 56 (44.1) |
| Overweight | 34 (34.0) | 57 (50.0) | 39 (33.1) | 34 (26.8) |
| Obese | 24 (24.0) | 17 (14.9) | 30 (25.4) | 35 (27.6) |
| Waist circumference (cm (SD)) # | 100.5 (14.4) | 97.8 (11.0) | 90.6 (14.4) | 88.6 (14.5) |
# Missing data: occupational status n = 3, alcohol consumption n = 3, smoking status n = 2, anti-inflammatory drugs n = 5, BMI and BMI categories n = 6, current physical activity n = 1, waist circumference n = 8. a other cancers included breast cancer, ovarian cancer, prostate cancer and skin cancers; b other included students, unemployed, and persons on parental leave. BMI = body mass index; CRC = colorectal cancer.
Summary of individuals at risk for cancer, events, and censorings occurring at the beginning of 10-year periods for men and women.
| Sex | Period | At Risk | All Cancers | CRC | ||
|---|---|---|---|---|---|---|
| Events | Censored | Events | Censored | |||
| Men | ||||||
| (20, 30) | 215 | 0 | 0 | 0 | 0 | |
| (30, 40) | 199 | 5 | 11 | 5 | 11 | |
| (40, 50) | 156 | 30 | 29 | 25 | 34 | |
| (50, 60) | 89 | 65 | 61 | 55 | 71 | |
| (60, 70) | 48 | 83 | 84 | 69 | 98 | |
| (70, 77) | 8 | 98 | 109 | 80 | 127 | |
| 77 | 0 | 98 | 117 | 80 | 135 | |
| Women | ||||||
| (20, 30) | 250 | 0 | 0 | 0 | 0 | |
| (30, 40) | 242 | 1 | 7 | 1 | 7 | |
| (40, 50) | 190 | 25 | 35 | 19 | 41 | |
| (50, 60) | 117 | 67 | 66 | 40 | 93 | |
| (60, 70) | 55 | 100 | 95 | 55 | 140 | |
| (70, 80) | 14 | 117 | 119 | 63 | 173 | |
| (80, 85) | 1 | 120 | 129 | 65 | 184 | |
| 85 | 0 | 120 | 130 | 65 | 185 | |
Period: A 10-year interval (years). At risk: participants at risk (n) at each 10-year interval. Events: cumulative n of occurred cancer events. Censored: cumulative n of censored participants. CRC = colorectal cancer. Note: for time interval lower limit includes the indicated value and the value for the upper limit is excluded.
Means and standard deviations for weight measurements (kg) and individual weight change in 10-year periods among participants with Lynch syndrome.
| Sex |
| Period | At Risk, Start of Period | Individual Change, Near-Term | Individual Change, Longitudinal | |||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |||
| Men | ||||||||
| 215 | (20, 30) | 72.65 | 11.93 | - | - | - | - | |
| 199 | (30, 40) | 77.06 | 12.68 | 5.06 | 5.99 | 5.06 | 5.99 | |
| 156 | (40, 50) | 79.56 | 14.91 | 3.76 | 7.05 | 8.23 | 10.29 | |
| 89 | (50, 60) | 79.67 | 12.43 | 4.03 | 6.73 | 10.61 | 10.52 | |
| 48 | (60, 70) | 77.05 | 11.76 | 0.72 | 4.10 | 8.22 | 9.25 | |
| 8 | (70, 77) | 83.40 | 15.37 | 4.60 | 7.09 | 12.20 | 12.28 | |
| Women | ||||||||
| 250 | (20, 30) | 59.16 | 11.28 | - | - | - | - | |
| 242 | (30, 40) | 62.88 | 13.48 | 3.96 | 6.59 | 3.96 | 6.59 | |
| 190 | (40, 50) | 66.30 | 14.78 | 3.98 | 5.86 | 7.53 | 8.72 | |
| 117 | (50, 60) | 68.30 | 13.65 | 2.83 | 6.11 | 9.33 | 10.29 | |
| 55 | (60, 70) | 68.98 | 11.58 | 2.85 | 4.41 | 9.39 | 9.24 | |
| 14 | (70, 80) | 73.91 | 12.84 | 4.73 | 9.02 | 13.18 | 11.97 | |
| 1 | (80, 85) | 79.00 | - a | 0.00 | - a | 20.00 | - a | |
a The variation is estimable only for one case. Period: A 10-year interval (years). Longitudinal change: change in body weight (kg) relative to the body weight at the age of 20 years. Near-term change: change in body weight (kg) relative to the body weight at the previous 10-year interval before diagnosis or censoring. Mean (kg). SD = standard deviation (kg). Note: for time interval lower limit includes the indicated value and the value for the upper limit is excluded.
Hazard ratios for associations of body weight and cancer risk in participants with Lynch syndrome.
| Setting | Unadjusted Model | Adjusted Model * | ||||||
|---|---|---|---|---|---|---|---|---|
| Cancer Events | Observations | HR (95% CI) | Cancer Events | Observations | HR (95% CI) | |||
| Men | ||||||||
| All cancers | ||||||||
| Longitudinal change | 77 | 610 | 1.02 (1.00–1.03) | 0.048 | 74 | 579 | 1.02 (1.00–1.04) | 0.022 |
| Near-term change | 77 | 185 | 0.99 (0.97–1.00) | 0.345 | 74 | 174 | 0.99 (0.97–1.01) | 0.424 |
| Colorectal cancer | ||||||||
| Longitudinal change | 60 | 610 | 1.02 (1.00–1.03) | 0.023 | 57 | 579 | 1.03 (1.01–1.05) | 0.004 |
| Near-term change | 60 | 185 | 1.00 (0.98–1.01) | 0.695 | 57 | 174 | 1.00 (0.98–1.02) | 0.861 |
| Women | ||||||||
| All cancers | ||||||||
| Longitudinal change | 95 | 758 | 0.99 (0.97–1.00) | 0.290 | 91 | 720 | 1.00 (0.98–1.02) | 0.887 |
| Near-term change | 95 | 221 | 0.98 (0.97–1.00) | 0.059 | 91 | 209 | 0.98 (0.96–1.00) | 0.059 |
| Colorectal cancer | ||||||||
| Longitudinal change | 50 | 758 | 0.99 (0.96–1.01) | 0.258 | 48 | 720 | 0.99 (0.96–1.02) | 0.454 |
| Near-term change | 50 | 221 | 0.98 (0.95–1.00) | 0.106 | 48 | 209 | 0.96 (0.92–0.99) | 0.015 |
* Model adjusted for height, MMR-gene, education, smoking, alcohol consumption, and use of anti-inflammatory drugs. Longitudinal change: longitudinal change in body weight from the age of 20 years until the first cancer diagnosis or censoring. Near-term change: age-stratified change in body weight relative to the body weight at the previous 10-year interval before diagnosis or censoring. p-values statistically significant at <0.05 level. Statistically significant hazard ratios are highlighted in bold. Cancer events: number of occurred cancers. Observations: number of observations across each 10-year interval. HR = hazard ratio. CI = confidence interval.
Frequencies and cross-period tables for participation in organized physical activity in 10-year periods among participants with Lynch syndrome.
| Sex | Period | Physical Activity | Near-Term Change | Longitudinal Change | |||
|---|---|---|---|---|---|---|---|
| Low Activity | High Activity | Low Activity | High Activity | ||||
| Men | (20, 30) | Low activity | 155 (76) | - | - | - | - |
| High activity | 50 (24) | - | - | - | - | ||
| (30, 40) | Low activity | 153 (81) | 131 (94) | 22 (44) | 131 (94) | 22 (44) | |
| High activity | 37 (19) | 9 (6) | 28 (54) | 9 (6) | 28 (56) | ||
| (40, 50) | Low activity | 129 (86) | 121 (98) | 8 (30) | 104 (95) | 25 (62) | |
| High activity | 21 (14) | 2 (2) | 19 (70) | 6 (5) | 15 (38) | ||
| (50, 60) | Low activity | 77 (91) | 70 (100) | 7 (47) | 59 (97) | 18 (75) | |
| High activity | 8 (9) | 0 (0) | 8 (53) | 2 (3) | 6 (25) | ||
| (60, 70) | Low activity | 43 (96) | 42 (100) | 1 (33) | 31 (100) | 12 (86) | |
| High activity | 2 (4) | 0 (0) | 2 (67) | 0 (0) | 2 (14) | ||
| (70, 77) | Low activity | 8 (100) | 8 (100) | 0 (-) | 6 (100) | 2 (100) | |
| High activity | 0 (0) | 0 (0) | 0 (-) | 0 (0) | 0 (0) | ||
| Women | (20, 30) | Low activity | 180 (76) | - | - | - | - |
| High activity | 58 (24) | - | - | - | - | ||
| (30, 40) | Low activity | 166 (72) | 151 (87) | 15 (26) | 151 (87) | 15 (26) | |
| High activity | 64 (28) | 22 (13) | 42 (74) | 22 (13) | 42 (74) | ||
| (40, 50) | Low activity | 121 (68) | 114 (87) | 7 (15) | 111 (92) | 31 (53) | |
| High activity | 58 (32) | 17 (13) | 41 (85) | 10 (8) | 27 (47) | ||
| (50, 60) | Low activity | 86 (77) | 75 (96) | 11 (32) | 82 (95) | 13 (50) | |
| High activity | 26 (23) | 3 (4) | 23 (68) | 4 (5) | 13 (50) | ||
| (60, 70) | Low activity | 40 (78) | 38 (97) | 2 (17) | 38 (95) | 5 (45) | |
| High activity | 11 (22) | 1 (3) | 10 (83) | 2 (5) | 6 (55) | ||
| (70, 77) | Low activity | 10 (83) | 10 (100) | 0 (0) | 10 (100) | 1 (50) | |
| High activity | 2 (17) | 0 (0) | 2 (100) | 0 (0) | 1 (50) | ||
Period: A 10-year interval (years). Physical activity: physical activity group at the beginning of the 10-year interval. Longitudinal change: change in physical activity group (n) relative to the physical activity group at the age of 20 years. Near-term change: change in physical activity group (n) relative to the physical activity group at the previous 10-year interval. Note: for time interval lower limit includes the indicated value and the value for the upper limit is excluded.
Hazard ratios for associations of physical activity and cancer risk in participants with Lynch syndrome.
| Setting | Unadjusted Model | Adjusted Model * | ||||||
|---|---|---|---|---|---|---|---|---|
| Cancer Events | Observations | HR (95% CI) | Cancer Events | Observations | HR (95% CI) | |||
| Men | ||||||||
| All cancers | ||||||||
| Longitudinal change | 91 | 683 | 0.44 (0.19–1.04) | 0.063 | 86 | 648 | 0.37 (0.15–0.98) | 0.044 |
| Near-term change | 91 | 205 | 0.69 (0.29–1.64) | 0.403 | 86 | 192 | 0.74 (0.27–2.01) | 0.557 |
| Colorectal cancer | ||||||||
| Longitudinal change | 73 | 683 | 0.57 (0.25–1.33) | 0.194 | 68 | 648 | 0.52 (0.20–1.36) | 0.181 |
| Near-term change | 73 | 205 | 0.93 (0.39–2.24) | 0.874 | 68 | 192 | 0.99 (0.36–2.73) | 0.983 |
| Women | ||||||||
| All cancers | ||||||||
| Longitudinal change | 110 | 823 | 1.31 (0.86–1.97) | 0.206 | 107 | 789 | 1.26 (0.79–2.00) | 0.341 |
| Near-term change | 110 | 238 | 1.42 (0.89–2.25) | 0.138 | 107 | 227 | 1.34 (0.80–2.23) | 0.268 |
| Colorectal cancer | ||||||||
| Longitudinal change | 59 | 823 | 1.16 (0.65–2.10) | 0.612 | 57 | 789 | 1.28 (0.65–2.52) | 0.471 |
| Near-term change | 59 | 238 | 0.92 (0.49–1.72) | 0.797 | 57 | 227 | 0.99 (0.48–2.02) | 0.973 |
* Model adjusted for MMR-gene, education, smoking, alcohol consumption, and use of anti-inflammatory drugs. In all analyses, the reference group was Low activity. Longitudinal change: longitudinal change in physical activity from the age of 20 years until the first cancer diagnosis or censoring. Near-term change: age-stratified change in physical activity level relative to the physical activity level at the previous 10-year interval before diagnosis or censoring. p-values statistically significant at the <0.05 level. Statistically significant hazard ratios are highlighted in bold. Cancer events: number of occurred cancers. Observations: number of observations across each 10-year interval. HR = hazard ratio. CI = confidence interval.